University Hospitals of Cleveland/Case Western
Welcome,         Profile    Billing    Logout  
 9 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Segal, Brahm
NCT04379518: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Suspended
1/2
64
US
Best Practice, standard of care, standard therapy, Recombinant Interferon Alfa-2b, Alfatronol, Glucoferon, Heberon Alfa, IFN alpha-2B, Interferon alfa 2b, Interferon Alfa-2B, Interferon Alpha-2b, Intron A, Sch 30500, Urifron, Viraferon, Rintatolimod, Ampligen, Atvogen
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed
11/23
11/23
Malek, Ehsan
DRAMMATIC, NCT04071457: S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Hourglass Jan 2023 - Jun 2023 : From trial for patients with r/r multiple myeloma treated with an IMiD and PI
Recruiting
3
1100
Canada, US
Lenalidomide, CC-5013, Revlimid, Daratumumab/rHuPH20
SWOG Cancer Research Network, National Cancer Institute (NCI), Janssen, LP
Multiple Myeloma
07/29
07/40
NCT02833610: A Study of Denosumab in Multiple Myeloma Patients with Renal Insufficiency

Completed
2
55
US
Denosumab Q4W, Xgeva, Prolia
Massachusetts General Hospital, Amgen, Emory University, University of Rochester, University Hospitals Cleveland Medical Center
Multiple Myeloma
03/23
03/23
CASE1A17, NCT03143985: Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Completed
1
18
US
Vactosertib, TEW-7197, EW7197, EW-7197, Pomalidomide, POM
Koen van Besien
Multiple Myeloma
02/22
09/22
NCT05013437: Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma

Withdrawn
1
20
US
Evomela, Melphalan, Next Generation Sequencing, Prochlorperazine, Acetaminophen, Diphenhydramine
Koen van Besien
Multiple Myeloma
12/23
03/24
NCT03591614: Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Withdrawn
1
18
US
DKK1
Case Comprehensive Cancer Center
Monoclonal Gammopathy, Smoldering Myeloma, Myeloma
08/24
08/25
NCT04685525: Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT

Withdrawn
N/A
40
US
Mycobiome Supporting Diet
Case Comprehensive Cancer Center
Autologous Transplant, Myeloma
12/24
06/25
Lazarus, Hillard
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
N/A
99999
US
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program
Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia
10/41
10/41
Callahan, Joyce
No trials found

Download Options